1st Quarter - Amendment

ABBVIE, INC. for ABBVIE INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$2,570,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2016 $2,630,000 Replaced
1st Quarter - Amendment (this page) Apr 20, 2016 $2,570,000 Replaced
1st Quarter - Amendment Jul 20, 2016 $26,000,000 Replaced
1st Quarter - Amendment Jul 20, 2016 $2,600,000 Replaced
1st Quarter - Amendment Oct 28, 2016 $2,610,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans-Atlantic Trade and Investment Partnership; Trans-Pacific Partnership Agreement; Trade Promotion Authority; Columbia-America Free Trade Agreement; Saudi Arabia Cancellation of Tender Issue; Japan Biannual Re-Pricing Issue; Plan COLOMBIA;

LobbyistCovered position, as disclosed
DANIEL BACHNER New General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Veterans Affairs, Dept of (VA); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS)

Taxation/Internal Revenue Code TAX

H.R. 880, American Research and Competitiveness Act of 2015; H.R. 1430, Permanent CFC Look-Through Act; H.R. 415 & S. 198, Stop Corporate Inversions Act; S. 1946, Tax Relief Extension Act of 2015; H.R. 1, Tax Reform Act of 2014; Administrations Tax Reform and 2017 Budget Proposals; Senate and House Committee Tax Reform Proposals; Puerto Rican Economy and Debt Relief Proposals (no bills introduced); Reps. Boustany and Neal: "Innovation Promotion Act" Discussion Draft Proposals to reform domestic and international tax structures (no bills introduced);

LobbyistCovered position, as disclosed
DANIEL BACHNER New General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Veterans Affairs, Dept of (VA); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 415 (114th), S. 198 (114th), H.R. 880 (114th), H.R. 1 (114th), S. 1946 (114th), H.R. 1430 (114th)

Copyright/Patent/Trademark CPT

H.R. 406 & S. 1767, Combination Drug Development Incentive Act of 2015; H.R. 1537 & S. 1878, Advancing Hope Act of 2015; S. 632, STRONG Patents Act of 2015; H.R. 9, Innovation Act; S. 2733, Venue Equity and Non-Uniformity Elimination Act of 2016; H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013; H.R. 971 & S. 1421, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015; S. 2615, Increasing Competition in Pharmaceuticals Act; Proposals/Initiatives related to international intellectual property protection;

LobbyistCovered position, as disclosed
DANIEL BACHNER New General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); SENATE

Bills named: S. 1767 (114th), S. 2615 (114th), S. 1421 (114th), H.R. 3709 (114th), H.R. 971 (114th), S. 1878 (114th), S. 632 (114th), H.R. 1537 (114th), H.R. 406 (114th), S. 2733 (114th), H.R. 9 (114th)

Health Issues HCR

H.R. 6, 21st Century Cures Act S. 2700, FDA and NIH Workforce Authorities Modernization Act; H.R. 3381, Childhood Cancer STAR Act; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 1101 & S. 1287, Viral Hepatitis Testing Act; Public Law 111-148, The Patient Protection and Affordable Care Act; H.R. 471 & S. 483, Ensuring Patient Access and Effective Drug Enforcement of 2015; H.R. 1725 & S. 480, National All Schedules Prescription Electronic Reporting Reauthorization of 2015; H.R. 2228 & S.122, Safe and Affordable Drugs from Canada Act of 2015; Proposals to address prescription drug abuse; Implementation of The Prescription Drug User Fee Act (PDUFA); Implementation of The Biosimilars User Fee Act (BsUFA); Public Law 113-54, Drug Quality & Security Act; H.R. 639 & S. 481, Improving Regulatory Transparency for New Medical Therapies; H.R. 2570 & S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act of 2015; H.R. 3677 Opioid Abuse Prevention and Treatment Act of 2015; S. 524, Comprehensive Addiction and Recovery Act of 2016;

LobbyistCovered position, as disclosed
DANIEL BACHNER New General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Natl Security Council (NSC); SENATE; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS)

Bills named: S. 481 (114th), H.R. 639 (114th), H.R. 3677 (114th), H.R. 471 (114th), S. 1287 (114th), S. 483 (114th), H.R. 1101 (114th), H.R. 3381 (114th), S. 524 (114th), S. 122 (114th), H.R. 2228 (114th), S. 2700 (114th), H.R. 1725 (114th), H.R. 2570 (114th), H.R. 6 (114th), S. 480 (114th), S. 1396 (114th)

Budget/Appropriations BUD

H.R. 4974 & S. 2806, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S. 2804, Energy and Water Development and Related Agencies Appropriations Act, 2017 (and related House bill not yet introduced); P.L. 114-113, Consolidated Appropriations Act, 2016 (H.R. 2029); Other Labor, Health and Human Services Appropriations (No Bills Introduced); Potential Amendments to Appropriations Bills (not introduced);

LobbyistCovered position, as disclosed
DANIEL BACHNER New General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Bills named: S. 2806 (114th), H.R. 4974 (114th), S. 2804 (114th), H.R. 2029 (114th)

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicaid; Policies to enhance patient access to medicines in Medicare; H.R. 3061 & S. 31, Medicare Prescription Drug Price Negotiation Act of 2015; H.R. 1102 & S. 117, Medicare Prescription Drug Price Negotiation Act; H.R. 2005 & S. 1083, Medicare Drug Savings Act; H.R. 3261 & S. 1884, Medicare Prescription Drug Savings and Choice Act of 2015; Medicare payment proposals;

LobbyistCovered position, as disclosed
DANIEL BACHNER New General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; State, Dept of (DOS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Natl Security Council (NSC)

Bills named: H.R. 3061 (114th), S. 1083 (114th), S. 31 (114th), S. 117 (114th), H.R. 1102 (114th), H.R. 2005 (114th), H.R. 3261 (114th), S. 1884 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.